Table 2 Etiological (inherited) profile of the study group
From: Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience
Control group | Thrombolysis group | p value | |
|---|---|---|---|
Factor V Leiden | 2 (4.5) | 2 (4.8) | 0.962 |
Prothrombin gene mutation | 0 (0) | 0 (0) | – |
Anti-thrombin III deficiency | 0 (0) | 0 (0) | – |
Protein C deficiency | 0 (0) | 1 (2.4) | 0.303 |
Protein S deficiency | 0 (0) | 3 (7.1) | 0.071 |
ANA/APLA | 4 (9.1) | 3 (7.1) | 0.741 |
Homocysteinemia | 1 (2.3) | 3 (7.1) | 1.149 |
JAK2 | 0 (0) | 2 (4.8) | 0.143 |